Finance

Lists
002728:SHE
Teyi Pharmaceutical Group Co Ltd
CNÂ¥9.72
+0.10%
(+0.010) 1D
Oct 15, 3:04:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002728...
Open
CNÂ¥9.64
High
CNÂ¥10.10
Low
CNÂ¥9.64
Mkt. cap
4.99B
Avg. vol.
18.43M
Volume
32.82M
Dividend
1.54%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
69.66
52-wk high
CNÂ¥15.21
52-wk low
CNÂ¥7.66
EPS
CNÂ¥0.14
Shares outstanding
513.31M
No. of employees
1K
Open
CNÂ¥9.64
High
CNÂ¥10.10
Low
CNÂ¥9.64
Mkt. cap
4.99B
Avg. vol.
18.43M
Volume
32.82M
Dividend
1.54%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
69.66
52-wk high
CNÂ¥15.21
52-wk low
CNÂ¥7.66
EPS
CNÂ¥0.14
Shares outstanding
513.31M
No. of employees
1K
News stories
From web sources and news partners
About Teyi Pharmaceutical Group Co Ltd
CEO-
Employees1.43K
FoundedMay 23, 2002
Headquarters-
SectorPharmaceutical industry
Websitetczy.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
200.71M
232.68M
209.87M
183.45M
Cost of goods sold
102.58M
123.26M
81.88M
87.55M
Cost of revenue
102.58M
123.26M
81.88M
87.55M
Research and development expenses
11.06M
14.19M
9.25M
11.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62.18M
83.64M
85.27M
75.71M
Operating expense
73.02M
102.76M
93.09M
88.23M
Total operating expenses
175.60M
226.01M
174.97M
175.78M
Operating income
25.11M
6.67M
34.91M
7.67M
Other non operating income
-755.83K
604.89K
-33.22K
-206.21K
EBT including unusual items
26.78M
7.45M
35.14M
7.17M
EBT excluding unusual items
24.81M
7.29M
35.61M
7.09M
Income tax expense
-433.06K
-9.00M
9.37M
1.83M
Effective tax rate
-1.62%
-120.80%
26.67%
25.48%
Other operating expenses
193.29K
4.17M
-340.24K
1.34M
Net income
27.21M
16.45M
25.76M
5.34M
Net profit margin
13.56%
7.07%
12.28%
2.91%
Earnings per share
-
-
-
-
Interest and investment income
1.03M
601.98K
1.52M
859.16K
Interest expense
-579.01K
-579.51K
-775.84K
-1.24M
Net interest expenses
449.92K
22.46K
742.40K
-376.54K
Depreciation and amortization charges
-
-
-
-
EBITDA
41.20M
24.12M
52.36M
26.35M
Gain or loss from assets sale
-83.37K
68.45K
-
-802.00
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps